Bioresorbable vascular scaffolds for complex coronary anatomies: "Icarus' flight" for interventional cardiologists?
作者信息
Cassese Salvatore, Kastrati Adnan, Fusaro Massimiliano
机构信息
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
出版信息
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S98-S101. doi: 10.21037/cdt.2017.01.10.
Abstract
摘要
相似文献
1
Bioresorbable vascular scaffolds for complex coronary anatomies: "Icarus' flight" for interventional cardiologists?用于复杂冠状动脉解剖结构的生物可吸收血管支架：介入心脏病学家的“伊卡洛斯之飞”？
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S98-S101. doi: 10.21037/cdt.2017.01.10.
2
Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds.亚太地区心脏病专家在使用生物可吸收支架方面的当前做法。
Int J Cardiol. 2016 Nov 1;222:832-840. doi: 10.1016/j.ijcard.2016.07.273. Epub 2016 Aug 1.
3
[Complex coronary intervention with overlapping of bioresorbable scaffolds. Case report and new insights review in the use of bioresorbable vascular scaffolds guided by optical coherence tomography].[生物可吸收支架重叠的复杂冠状动脉介入治疗。光学相干断层扫描引导下生物可吸收血管支架应用的病例报告及新见解综述]
Arch Cardiol Mex. 2016 Apr-Jun;86(2):170-4. doi: 10.1016/j.acmx.2016.01.003. Epub 2016 Feb 21.
4
Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.用于治疗冠状动脉分叉病变的生物可吸收支架：批判性评估与未来展望。
Catheter Cardiovasc Interv. 2016 Sep;88(3):397-406. doi: 10.1002/ccd.26454. Epub 2016 May 3.
5
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.依维莫司洗脱生物可吸收血管支架与依维莫司洗脱金属支架的比较：随机对照试验的荟萃分析。
Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17.
6
Bioresorbable scaffolds for complex coronary interventions.
Minerva Cardioangiol. 2018 Aug;66(4):477-488. doi: 10.23736/S0026-4725.18.04660-1. Epub 2018 Mar 15.
7
Bioresorbable scaffolds for coronary artery disease: current status and future prospective.用于冠状动脉疾病的生物可吸收支架：现状与未来展望。
Chin Med J (Engl). 2014;127(6):1141-8.
8
Absorb Bioresorbable Vascular Scaffold in Complex Coronary Bifurcation Interventions: Insights From an In Vivo Multimodality Imaging Study.在复杂冠状动脉分叉病变介入治疗中应用可吸收生物可降解血管支架：一项体内多模态影像学研究的启示。
Circ Cardiovasc Interv. 2016 Aug;9(8). doi: 10.1161/CIRCINTERVENTIONS.116.003849.
9
Bioresorbable Scaffolds for Coronary Stenosis: When and How Based Upon Current Studies.用于冠状动脉狭窄的生物可吸收支架：基于当前研究的时机与方式
Curr Cardiol Rep. 2017 Mar;19(3):27. doi: 10.1007/s11886-017-0836-z.
10
Fully bioresorbable vascular scaffolds: lessons learned and future directions.完全生物可吸收血管支架：经验教训与未来方向。
Nat Rev Cardiol. 2019 May;16(5):286-304. doi: 10.1038/s41569-018-0124-7.
本文引用的文献
1
Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy.真实世界应用优化植入策略的生物可吸收血管支架植入后临床结局的研究。
EuroIntervention. 2017 Feb 20;12(14):1730-1737. doi: 10.4244/EIJ-D-16-00247.
2
Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial.依维莫司洗脱生物可吸收支架与依维莫司洗脱金属支架植入术后的两年临床、血管造影及光学相干断层扫描连续随访：来自日本随机ABSORB试验的见解
EuroIntervention. 2016 Oct 20;12(9):1090-1101. doi: 10.4244/EIJY16M09_01.
3
Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原位冠状动脉病变所致缺血性心脏病的随机对照研究：ABSORB II试验的2年临床结果
EuroIntervention. 2016 Oct 20;12(9):1102-1107. doi: 10.4244/EIJY16M08_01.
4
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria.SYNTAX 评分和 ABSORB II 研究入选标准分层的复杂冠状动脉疾病患者中 Absorb 生物可吸收血管支架植入术的 2 年临床结果。
EuroIntervention. 2016 Aug 5;12(5):e557-65. doi: 10.4244/EIJV12I5A95.
5
Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry.依维莫司洗脱生物可吸收血管支架治疗患者的中期至长期临床结局：BVS Expand 注册研究。
JACC Cardiovasc Interv. 2016 Aug 22;9(16):1652-63. doi: 10.1016/j.jcin.2016.04.035. Epub 2016 Jul 27.
6
Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.冠状动脉生物可吸收血管支架在冠状动脉疾病治疗中的应用。
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.116.003978.
7
Bioresorbable Vascular Scaffolds for Coronary Revascularization.用于冠状动脉血运重建的生物可吸收血管支架
Circulation. 2016 Jul 12;134(2):168-82. doi: 10.1161/CIRCULATIONAHA.116.021539.
8
Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update.ST段抬高型心肌梗死患者生物可吸收血管支架植入术后的长期随访：PRAGUE-19研究更新
EuroIntervention. 2016 May 17;12(1):23-9. doi: 10.4244/EIJV12I1A5.
9
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.生物可吸收血管支架与依维莫司洗脱金属支架用于ST段抬高型心肌梗死的比较（BVS EXAMINATION研究）：倾向评分匹配比较的2年结果
Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7.
10
Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.生物可吸收血管支架治疗冠状动脉支架内再狭窄的长期临床结果：意大利多中心经验。
Circ Cardiovasc Interv. 2016 Apr;9(4):e003148. doi: 10.1161/CIRCINTERVENTIONS.115.003148.
Zotero 插件